3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
91
Leukemia, Lymphocytic, Chronic, B-Cell
28
Myelodysplastic Syndromes
18
Recurrence
9
Lymphoma, Mantle-Cell
9
Leukemia, Biphenotypic, Acute
8
Burkitt Lymphoma
8
Waldenstrom Macroglobulinemia
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma
6
Hematologic Neoplasms
6
Lymphoma, Follicular
4
Myeloproliferative Disorders
3
Multiple Myeloma
3
Anemia, Refractory, with Excess of Blasts
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, B-Cell
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Blast Crisis
2
Venentoclax
1
Targeted Therapy
1
Sarcoma, Myeloid
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Busulfan
4
ruxolitinib
3
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Melphalan
3
Thiotepa
2
Specimen Handling
2
Sirolimus
2
Cyclosporine
2
belumosudil
1
axatilimab
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Methotrexate
1
Low-Level Light Therapy
1
Leukocyte Count
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Emapalumab
1
Drug Therapy
1
Clofarabine
1
Clinical Trials, Phase I as Topic
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
venetoclax
×
90 days
×
Clear all
No trials found.